Greenwich LifeSciences GLSI
NASDAQ GLSI
$18.38 -0.21 (-1.13%)
At close: Sep 29, 2026 · 4:00 PM EDT

Greenwich LifeSciences (GLSI) Share-based Compensation (2020 - 2026)

Updated

Greenwich LifeSciences' Share-based Compensation came in at $1.54 million for Q1 2026, unchanged from $1.54 million a year earlier and down 28.9% from the prior quarter.

Analysis

Greenwich LifeSciences (GLSI) Share-based Compensation (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Mar 31, 2026, Greenwich LifeSciences reported Share-based Compensation of $6.8 million, down 17.1% year-over-year; for FY2025, it was $6.8 million, down 6.2% from FY2024.

  • Share-based Compensation carries a five-year compound annual growth rate of 58.6% (FY2020 to FY2025).
  • Going back by year, Share-based Compensation was $7.25 million in FY2024 (+205.0%), $2.38 million in FY2023 (+36.4%), $1.74 million in FY2022 (+164.0%) and $660,582 in FY2021 (-2.6%).
  • The five-year range for quarterly Share-based Compensation is $165,051 (Q2 2021) to $5.47 million (Q4 2024).
  • Year-over-year, Share-based Compensation increased in four of the last eight quarters, with growth averaging 154.9%.
  • The fastest year-over-year change in Share-based Compensation over five years came in Q4 2024 (growth of 820.0%), and the weakest in Q4 2025 (a decline of 60.3%).
  • Business Quant data shows GLSI's Share-based Compensation at $2.17 million (Q4 2025), $1.54 million (Q3 2025) and $1.54 million (Q2 2025) in the three quarters before Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Greenwich LifeSciences 272.64 Mn 272.64 Mn - 1.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.54 Mn
Dec 31, 2025 2.17 Mn
Sep 30, 2025 1.54 Mn
Jun 30, 2025 1.54 Mn
Mar 31, 2025 1.54 Mn
Dec 31, 2024 5.47 Mn
Sep 30, 2024 594,522.00
Jun 30, 2024 594,522.00
Mar 31, 2024 594,522.00
Dec 31, 2023 594,522.00
Sep 30, 2023 594,522.00
Jun 30, 2023 594,522.00
Mar 31, 2023 594,522.00
Dec 31, 2022 594,522.00
Sep 30, 2022 759,573.00
Jun 30, 2022 224,503.00
Mar 31, 2022 165,267.00
Dec 31, 2021 165,429.00
Sep 30, 2021 165,051.00
Jun 30, 2021 165,051.00
API Access

Greenwich LifeSciences Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=GLSI&period=max&api_key=YOUR_API_KEY